Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$8.99 - $10.74 $219,356 - $262,056
-24,400 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$9.14 - $11.97 $223,016 - $292,068
24,400 New
24,400 $252,000
Q4 2018

Feb 12, 2019

SELL
$7.8 - $16.13 $120,120 - $248,401
-15,400 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$14.31 - $17.65 $220,374 - $271,810
15,400 New
15,400 $284,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $679M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.